Ausgabe 1/2024
Inhalt (18 Artikel)
The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition
Takehiko Sakai, Goro Kutomi, Tadahiko Shien, Sota Asaga, Tomoyuki Aruga, Makoto Ishitobi, Sayaka Kuba, Masataka Sawaki, Kaori Terata, Koichi Tomita, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition
Naoko Honma, Masayuki Yoshida, Keiichi Kinowaki, Rie Horii, Yuka Katsurada, Yuya Murata, Ai Shimizu, Yuko Tanabe, Chikako Yamauchi, Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji
Annual report of the Japanese Breast Cancer Registry for 2019
Minoru Miyashita, Hiraku Kumamaru, Naoki Niikura, Yasuaki Sagara, Takaaki Konishi, Takayuki Iwamoto, Naoko Sanuki, Kenta Tanakura, Masayuki Nagahashi, Naoki Hayashi, Masayuki Yoshida, Chie Watanabe, Naoko Kinukawa, Masakazu Toi, Shigehira Saji
Rethinking screening mammography in Japan: next-generation breast cancer screening through breast awareness and supplemental ultrasonography
Takayoshi Uematsu
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer
Yoshitaka Fujiki, Masahiro Kashiwaba, Mutsumi Sato, Junko Kawano, Megumi Teraoka, Shuichi Kanemitsu, Yoshiaki Rai, Tetsuhiko Taira, Yoshiaki Sagara, Yasuyo Ohi, Uiree Jo, Young-Won Lee, Sae Byul Lee, Gyungyub Gong, Young Kee Shin, Mi Jeong Kwon, Yasuaki Sagara
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study
Linghui Kong, Zhen Yang, Chen Zheng, Tingting Lu, Huijun Zhang
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole
Masato Takahashi, Tomofumi Osako, Hiroyuki Yasojima, Kenichi Inoue, Masahiro Kawashima, Hideki Maeda, Akemi Ichikawa, Yasuaki Muramatsu, Norikazu Masuda
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer
Asumi Iesato, Atsushi Fushimi, Rie Tahara, Mitsuo Terada, Madoka Iwase, Chihiro Kawamura, Nami Yamashita
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective study
Masahiro Yoshida, Ryo-ichi Yoshimura, Ryoichi Notake, Hidenori Shinjo, Kazunori Miyaura, Takashi Kuwayama, Takashi Kawanaka, Tadahiko Shien, Kotaro Yoshio, Toshiko Shiga, Yuko Kaneyasu, Tsuyoshi Nakagawa, Kazunori Kubota, Seigo Nakamura, Jun Itami
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy
Mellissa Williamson, David J. Press, Svenn Alexander Hansen, Akanksha Tomar, Gurleen Singh Jhuti, Cedric Revil, Kaustubh Gururaj
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer
Xiaowei Shen, Ganggang Wang, Hua He, Ping Shang, Bin Yan, Xiaoliang Wang, Weixing Shen
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan
Yoshitaka Nishikawa, Nobukazu Agatsuma, Takahiro Utsumi, Taro Funakoshi, Yukiko Mori, Yuki Nakamura, Nobuaki Hoshino, Takahiro Horimatsu, Takumi Saito, Soichiro Kashihara, Jun Fukuyoshi, Rei Goto, Masakazu Toi, Yoshimitsu Takahashi, Takeo Nakayama
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels
Amira Fathy, Mohamed A. Abdelrazek, Abdelfattah M. Attallah, Amr Abouzid, Mohamed El-Far
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study
Florian Pelzer, Wilfried Tröger, Marcus Reif, Susanne Schönberg, David D. Martin, Cornelia Müller, Isabell Utz-Billing, Thorsten Kühn, Stephan Baumgartner, Marion Kiechle, Daniela Paepke
IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G
Rui Jing, Shukun Bai, Peipei Zhang, Hao Ren, Lintao Jia, Weimiao Li, Guoxu Zheng
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer
Helle Pappot, Benóný P. Björnsson, Oswin Krause, Christina Bæksted, Pernille E. Bidstrup, Susanne O. Dalton, Christoffer Johansen, Ann Knoop, Ivan Vogelius, Cecilie Holländer-Mieritz
Are breast cancer subtypes different in breast cancer patients with and without hepatitis C virus infection?
Kadri Altundag